Seems I need to clear up some issues for Drano and anyone else who read my posts today. Hopefully this will satisfy all involved and sorry for any lapse of memory or misunderstanding. As I noted to Drano in PM conversation, it has been well over a decade since I prescribed any antifungal due to change in practice venue and actually has probably been closer to two decades since I've done it routinely so my memory was a little fuzzy and I didn't feel the need to refresh it while trying to make what I thought was a simple side point. When I was trained (in the 1980's) we were often more limited in available drug forms to give and the vaginal troche (Mycelex if I recall from the time) was one of the only readily available ways to reach a higher concentration of drug to the involved site for oral candida infection than the commonly used oral antifungal rinses (of which several were available but also often not highly effective). It sounds strange and we always explained to the patient the logic behind its use for the more intractable infections but it often worked where the oral rinses would not. My simple point was that a "swish and spit" delivery is often difficult if not impossible for OM patients and for that reason other delivery methods might be more effective in the future. Pastilles/lozenges have become available in more recent years for oral administration in treatment of fungal infection, possibly an example of such off label uses of other forms of the drugs in years past.
I never suggested that any antifungal was used to treat oral mucositis (read the post carefully and you will see that). The antifungal was mentioned to note an "off label" use of a medication and a possibility of future change to delivery method of Brilacidin to target this limited/specific physiological site. I certainly do not know more than the scientists at IPIX and I am confident that they will maximize effectiveness of delivery.
Read Drano post 39588 12/4/17 and then search "can the flu shot give you the flu" and read the CDC information. A phd friend got the flu after receiving the flu shot so it must have been from the shot. Couldn't have been that he was already exposed and in development at the time of the shot, could it?
Not my intent to single anyone out here but I stand by all my earlier statements, as confusing and dated as they may have been. It is always important to do your own DD and reasoning before accepting anything you read on the internet.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Category: StocksTotal Views: 162 By : Lucas YoungUpdated: 07-28-2024
Windtree Therapeutics Updates Istaroxime Clinical Development and Trial Data
Providing a thorough update on the clinical and business development of istaroxime, Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company committed to developing creative therapies for critical diseases, has This first-in-class treatment seeks to raise blood pressure, preserve or increase renal function, and strengthen systolic contraction and diastolic relaxation of the heart. In three Phase 2 trials... Continue Reading
SEC Charges Andrew Left and Citron Capital in $20 Million Fraud Scheme
Andrew Left and his company, Citron Capital LLC, have been charged with a $20 million fraud by the Securities and Exchange Commission (SEC). They are activists short sellers. The SEC complaint claims Left recommended stock positions using his Citron Research website and social media platform. He said these positions complemented Citron Capital's and his own investments. Left's recommendations, according to the SEC,... Continue Reading
BurgerFi International Settles Litigation with Lion Point Capital
The owner of Anthony's Coal Fired Pizza & Wings and BurgerFi brand, BurgerFi International, Inc. (NASDAQ: BFI, BFIIW), revealed a sizable settlement with Lion Point Capital, LP. This agreement settles all outstanding claims brought by Lion Point against BurgerFi since the litigation started.
BurgerFi will pay Lion Point $1,350,000 in installments per terms of the settlement. BurgerFi will also issue Lion Point 300,00... Continue Reading
Upcoming Earnings Reports from Tech Giants
The earnings reports from some of the most well-known tech companies—including Microsoft, Apple, Amazon, and Meta Platforms—are much awaited by investors. These studies are vital since they might either calm the market or cause more volatility. A rally in tech stocks stalled in the second half of July, which caused a notable selloff following Tesla and Alphabet's underperformance. The results this week will be a litmus test for the ma... Continue Reading
Trump Champions U.S. Bitcoin Reserve at Bitcoin Conference
At the Bitcoin Conference in Nashville, former US President Donald Trump declared his endorsement of a strategic national bitcoin reserve. He underlined the need to keep the government's seized bitcoin intact and never sell it. This action seeks to confirm his ranking as the preferred candidate for the crypto community. With his audacious crypto policies, Trump's speech drew in over 3,000 people. The announcement fits the increa... Continue Reading
China's Industrial Profits Accelerate in June
China's industrial gains in June increased more quickly, a reflection of good economic trends despite underlying problems. Official figures revealed a 3.6% year-on-year rise in profits, against a 0.7% increase in May. Strong industry output, according to the National Bureau of Statistics (NBS), helped to explain this increase. Since the second quarter also had a major influence, the easing of factory-gate price declines also reflects. This... Continue Reading
Anticipation Builds for Major Tech Earnings
Earnings reports from big tech companies are much awaited by investors, who might shape the direction of American stock markets. Next week Microsoft, Apple, Amazon, and Meta Platforms have to report their quarterly results. The tech industry has shown notable volatility; recent results from Alphabet and Tesla let down the market. This begs questions regarding whether other tech behemoths can satisfy great expectations. These firms' performance i... Continue Reading
Understanding the Basics of Bonds
Bonds are debt instruments companies use to generate capital. Bonds are bought by investors, so the issuing body lends funds. The issuer promises to pay interest at regular intervals in exchange, then return the principal amount on the maturity date. For bondholders, this procedure produces a consistent income source. Bonds can help to lower general volatility and diversify a portfolio. These are often considered safer investments than stocks. Still, knowledg... Continue Reading
Global Stocks Rebound After Four-Day Decline
Friday's global stocks show a notable comeback, the first increase in four sessions. Following a dramatic selloff, this recovery found equities stable among bettering economic signals. Data showing a small rise in the personal consumption expenditures (PCE) price index were published by the Commerce Department. Last month this index—a Federal Reserve preferred inflation gauge—rose 0.1%. The statistics implied a possible relaxation o... Continue Reading
OpenAI Unveils SearchGPT: A New Era in Search Technology
Recently OpenAI revealed a prototype of its own search engine, SearchGPT. This instrument seeks to give users quick, accurate responses backed by pertinent, clear sources. Under alpha testing with a small group of users, SearchGPT promises to transform online information search. This tool is meant to be included into the viral chatbot ChatGPT so that a more natural and simple search experience is enabled. Like in a conversation, users w... Continue Reading